Dis-Chem Pharmacies Limited (JSE:DCP)
South Africa
· Delayed Price · Currency is ZAR · Price in ZAc | Market Cap | 31.28B |
| Revenue (ttm) | 40.88B |
| Net Income (ttm) | 1.24B |
| Shares Out | 856.96M |
| EPS (ttm) | 1.44 |
| PE Ratio | 25.36 |
| Forward PE | 25.45 |
| Dividend | 0.59 (1.61%) |
| Ex-Dividend Date | Nov 19, 2025 |
| Volume | 473,807 |
| Average Volume | 960,858 |
| Open | 3,649.00 |
| Previous Close | 3,650.00 |
| Day's Range | 3,577.00 - 3,649.00 |
| 52-Week Range | 3,020.00 - 3,900.00 |
| Beta | 0.43 |
| RSI | 49.45 |
| Earnings Date | May 29, 2026 |
About Dis-Chem Pharmacies
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensary, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products in the wholesale market. In addition, it offers customer loyalty programs... [Read more]
Financial Performance
In fiscal year 2025, Dis-Chem Pharmacies's revenue was 39.17 billion, an increase of 7.96% compared to the previous year's 36.28 billion. Earnings were 1.18 billion, an increase of 19.84%.
Financial StatementsNews
Dis-Chem Pharmacies Ltd (JSE:DCP) (Q2 2026) Earnings Call Highlights: Strong Retail and ...
Dis-Chem Pharmacies Ltd (JSE:DCP) (Q2 2026) Earnings Call Highlights: Strong Retail and Wholesale Growth Amid Strategic Investments
Half Year 2026 Dis-Chem Pharmacies Ltd Earnings Call Transcript
Half Year 2026 Dis-Chem Pharmacies Ltd Earnings Call Transcript
Dis-Chem Pharmacies Earnings Call Transcript: H1 2026
Group delivered strong H1 FY2026 results with 8.7% revenue growth, 9.9% total income growth, and 25.8% core retail profitability increase (excluding ecosystem investments). Major investments in digital, loyalty, and healthcare ecosystem are driving transformation and future growth.
Dis-Chem Pharmacies Earnings Call Transcript: H2 2025
Strong revenue and profit growth driven by property expansion, cost control, and wholesale market share gains. Integrated healthcare ecosystem and digital innovation initiatives advanced, with significant investments in new stores, technology, and working capital optimization.
Dis-Chem Pharmacies Ltd (JSE:DCP) Half Year 2025 Earnings Call Highlights: Strong Revenue ...
Dis-Chem Pharmacies Ltd (JSE:DCP) Half Year 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Pressures
Half Year 2025 Dis-Chem Pharmacies Ltd Earnings Call Transcript
Half Year 2025 Dis-Chem Pharmacies Ltd Earnings Call Transcript
Dis-Chem Pharmacies Earnings Call Transcript: H1 2025
Revenue grew 11.1% to ZAR 36.3bn, with strong H2 profit and cost control. Retail and wholesale segments delivered double-digit growth, while investments in property, digital, and integrated healthcare support future expansion. Tough trading conditions are expected to persist.
Dis-Chem versus Clicks
South Africa’s two largest pharmacy chains, Dis-Chem and Clicks, are fighting for market share. Here is the scoreboard.